A class of drugs used to treat breast, ovarian, prostate and other cancers selectively exploits self-repair and surveillance defects of cancer cells carrying BRCA1 and BRCA2 mutations.
Hereditary Breast Ovarian Cancer Syndrome (BRCA1 / BRCA2)
Hereditary breast ovarian cancer syndrome is an abnormal version of the gene BRCA1 or BRCA2, which increases a person�s risk of developing various types of cancer
Adjuvant therapy is a term used to describe interventions given before or after tumor surgery to maximize the effectiveness of cancer treatment, which includes chemotherapy, radiation and the newer targeted and biological therapies.
We help to identify families that may have a hereditary breast and/or ovarian cancer syndrome and, when indicated, offer genetic testing, cancer screening and support.
Staffed by a team fully dedicated to breast imaging, Mass General Imaging offers access to breast imaging services at many community locations to provide you with the highest level of advanced quality care.
Massachusetts General Hospital's Pain Management Center offers advanced pain management therapies for patients experiencing moderate to severe levels of cancer-related pain.
News & Publications
The purpose of this study was to quantify and describe the amount of waste generated by an Emergency Department, identify deviations from waste policy and explore areas for waste reduction.
Our publication keeps health care professionals up to date on the latest research and clinical advances from Mass General.
News and notes from the largest hospital-based research program in the United States
The Patient Gateway provides secure online access to your health information whenever you need it. Check upcoming appointments, communicate with your doctor’s office, review medications and pay medical bills—all seamlessly online 24/7.